Porton Pharma Solutions Ltd. (SHE:300363)
23.79
+0.42 (1.80%)
Feb 3, 2026, 3:04 PM CST
Porton Pharma Solutions Revenue
Porton Pharma Solutions had revenue of 923.49M CNY in the quarter ending September 30, 2025, with 19.44% growth. This brings the company's revenue in the last twelve months to 3.43B, up 24.51% year-over-year. In the year 2024, Porton Pharma Solutions had annual revenue of 3.01B, down -17.87%.
Revenue (ttm)
3.43B
Revenue Growth
+24.51%
P/S Ratio
3.68
Revenue / Employee
814.23K
Employees
4,200
Market Cap
12.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.01B | -655.45M | -17.87% |
| Dec 31, 2023 | 3.67B | -3.37B | -47.87% |
| Jan 1, 2023 | 7.03B | 3.93B | 126.55% |
| Jan 1, 2022 | 3.11B | 1.03B | 49.87% |
| Dec 31, 2020 | 2.07B | 520.58M | 33.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Hisun Pharmaceutical | 9.84B |
| Shanghai Shyndec Pharmaceutical | 9.36B |
| Zhejiang Medicine | 8.96B |
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| Henan Lingrui Pharmaceutical | 3.78B |
| Mayinglong Pharmaceutical Group | 3.77B |
| Beijing Foyou Pharma CO.,LTD | 3.42B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 2.72B |